25746-87-6

Usage

Uses

Used in Pharmaceutical Synthesis:
4-(DIMETHOXYMETHYL)PYRIMIDINE is used as a synthetic intermediate for the development of new pharmaceutical compounds. Its unique structure allows it to be a key building block in the creation of various drugs, particularly those targeting different medical conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 4-(DIMETHOXYMETHYL)PYRIMIDINE is used as a starting material for the synthesis of novel therapeutic agents. Its chemical properties make it an attractive candidate for the development of new drugs with improved efficacy and reduced side effects.
Used in Drug Design:
4-(DIMETHOXYMETHYL)PYRIMIDINE is also utilized in drug design, where its structural features can be exploited to create molecules with specific biological activities. 4-(DIMETHOXYMETHYL)PYRIMIDINE can be modified and optimized to target various receptors and enzymes, leading to the development of more effective treatments for a wide range of diseases.
Used in Chemical Research:
In addition to its applications in the pharmaceutical industry, 4-(DIMETHOXYMETHYL)PYRIMIDINE is also used in chemical research to study the properties and reactivity of pyrimidine-based compounds. This research can lead to a better understanding of the underlying chemistry and the development of new synthetic methods and strategies.

InChI:InChI=1/C7H10N2O2/c1-10-7(11-2)6-3-4-8-5-9-6/h3-5,7H,1-2H3

Upstream product

• 67751-23-9 (E)-4-(dimethylamino)-1,1-dimethoxybut-3-en-2-one 
• 3473-63-0 formamidine acetic acid 
• 6342-56-9 Pyruvic aldehyde dimethyl acetal 

Downstream Products

• 28643-92-7 oxime du pyrimidine-4 carboxaldehyde 
• 82298-80-4 N-Pyrimidin-4-ylmethyl-formamide 
• 82298-81-5 N-Pyrimidin-4-ylmethyl-acetamide 
• 45588-79-2 1-(pyrimidin-4-yl)methanamine 
• 2435-50-9 pyrimidine-4-carboxaldehyde 
• 1293396-29-8 tert-Butyl 4-{[(1E)-pyrimidin-4-ylmethylene]amino}piperidine-1-carboxylate 
• 1293396-31-2 4-[4-(4-Fluorophenyl)-1-piperidin-4-yl-1H-imidazol-5-yl]pyrimidine 
• 1293396-37-8 tert-Butyl 4-(4-phenyl-5-pyrimidin-4-yl-1H-imidazol-1-yl)piperidine-1-carboxylate 
• 760211-80-1 4-(4-phenyl-1-piperidin-4-yl-1H-imidazol-5-yl)pyrimidine 
• 1293396-45-8 tert-butyl 4-[4-(4-fluorophenyl)-2-methyl-5-pyrimidin-4-yl-1H-imidazol-1-yl]piperidine-1-carboxylate 
• 1293396-30-1 tert-butyl 4-[4-(4-fluorophenyl)-5-pyrimidin-4-yl-1H-imidazol-1-yl]piperidine-1-carboxylate 
• 1293395-72-8 4-[4-(4-fluorophenyl)-1-{1-[(1R)-1-isoxazol-3-ylethyl]piperidin-4-yl}-1H-imidazol-5-yl]pyrimidine 
• 1293395-73-9 4-[4-(4-fluorophenyl)-1-{1-[(1S)-1-isoxazol-3-ylethyl]piperidin-4-yl}-1H-imidazol-5-yl]pyrimidine 
• 1293396-44-7 N-[1-(4-fluorophenyl)-2-oxo-2-pyrimidin-4-ylethyl]acetamide 

Relevant academic research and scientific papers

Novel Compounds As Casein Kinase Inhibitors

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

ISOXAZOLO-PYRIDAZINE DERIVATIVES

The invention relates to isoxazolo-pyridazine compounds, in particular those of formula I as described above and to a pharmaceutically acceptable salts thereof, having affinity and selectivity for the GABA A α5 receptor binding site, their manufacture, pharmaceutical compositions containing them and their use as cognitive enhancers or for the treatment of cognitive disorders like Alzheimer's disease.